Related Experiment Video
Updated: Feb 14, 2026

14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
33.7K
[Respiratory Failure: Innovations in Diagnostics and Therapy]
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS
|February 10, 2018
Summary
Individualized mechanical ventilation is crucial for respiratory failure. Lung-protective strategies, including adequate PEEP and tidal volume, alongside early mobilization, optimize patient outcomes.
Area of Science:
- Critical Care Medicine
- Respiratory Physiology
- Mechanical Ventilation
Background:
- Acute and chronic respiratory failures necessitate prompt diagnosis and tailored ventilation strategies.
- Non-invasive ventilation is preferred to mitigate risks associated with invasive mechanical ventilation, but may be unsuitable for moderate to severe ARDS.
- Individualized adjustment of invasive mechanical ventilation parameters is essential.
Purpose of the Study:
- To review current evidence and best practices for mechanical ventilation in respiratory failure.
- To highlight the importance of individualized ventilation therapy.
- To discuss future directions in monitoring and personalizing ventilator settings.
Main Methods:
- Review of current evidence-based guidelines for mechanical ventilation.
- Discussion of physiological parameters and monitoring techniques for individualizing therapy.
- Emphasis on implementing established lung-protective ventilation strategies.
Main Results:
- Lung-protective ventilation, incorporating adequate Positive End-Expiratory Pressure (PEEP) and tidal volumes (6-8 ml/kg IBW), is recommended.
- Limiting peak or driving pressure is a key component of safe mechanical ventilation.
- Future advancements may include transpulmonary pressure monitoring and electrical impedance tomography for enhanced individualization.
Conclusions:
- Current evidence supports implementing lung-protective ventilation with individualized PEEP, tidal volume, and pressure limitations.
- Early mobilization, prone positioning, score-based sedation, and individualized volume therapy are critical adjuncts.
- Despite promising future technologies, consistent application of current best practices remains paramount.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
642
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
642
Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V
519
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
519
Acute Respiratory Failure-III
958
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
958
Acute Respiratory Failure-IV
591
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
591

